Investing.com - Bristol-Myers Squibb (NYSE:BMY) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Bristol-Myers Squibb announced earnings per share of $1.93 on revenue of $11.89B. Analysts polled by Investing.com anticipated EPS of $1.8 on revenue of $11.44B.
Bristol-Myers Squibb shares are down 22% from the beginning of the year and are trading at $71.83 , down-from-52-week-high.They are under-performing the S&P 500 which is down 17.73% from the start of the year.
Bristol-Myers Squibb shares lost 2.44% in pre-market trade the report.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar